Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      USFDA Caution: Lupin Pithampur facility likely to face regulatory action

      USFDA Caution: Lupin Pithampur facility likely to face regulatory action

      Farhat Nasim24 April 2019 10:00 AM IST
      Lupin, however, said it does not believe that the classification would have an impact on the disruption of supplies or the existing revenues from...
      Roche launches VENTANA HER2 Dual ISH DNA Probe Cocktail for breast, gastric cancer detection

      Roche launches VENTANA HER2 Dual ISH DNA Probe Cocktail for breast, gastric cancer detection

      Farhat Nasim24 April 2019 9:45 AM IST
      New Delhi: Drug firm Roche has recently announced the launch of the new VENTANA HER2 Dual ISH DNA Probe Cocktail assay for the detection of the HER2...
      Mylan, TB Alliance to commercialize Pretomanid to treat TB

      Mylan, TB Alliance to commercialize Pretomanid to treat TB

      Farhat Nasim23 April 2019 10:00 AM IST
      TB Alliance began preclinical development of pretomanid in 2002, and it has since studied pretomanid in 20 clinical trials alone or in combination...
      Eli Lilly to sell legacy antibiotics brands Ceclor, Vancocin, China facility to Eddingpharm

      Eli Lilly to sell legacy antibiotics brands Ceclor, Vancocin, China facility to Eddingpharm

      Farhat Nasim23 April 2019 9:45 AM IST
      INDIANAPOLIS: Eli Lilly and Company today announced that it has entered into an agreement to sell the rights in China for two legacy Lilly antibiotic...
      Alembic Pharma gets USFDA nod toTeriflunomide tablets, Tobramycin ophthalmic solution

      Alembic Pharma gets USFDA nod toTeriflunomide tablets, Tobramycin ophthalmic solution

      Farhat Nasim22 April 2019 11:55 AM IST
      Teriflunomide tablets are indicated for the treatment of patients with relapsing forms of multiple sclerosis while Tobramycin ophthalmic solution is a...
      Torrent Pharma recalls over 10.78 lakh bottles of Losartan citing CGMP deviations

      Torrent Pharma recalls over 10.78 lakh bottles of Losartan citing CGMP deviations

      Farhat Nasim22 April 2019 11:51 AM IST
      The US-based arm of Torrent Pharmaceuticals is recalling 133,992 bottles of Losartan Potassium tablets USP in the strength of 25 mg manufactured by...
      Merck wins USFDA approval for Keytruda as combo therapy for kidney cancer

      Merck wins USFDA approval for Keytruda as combo therapy for kidney cancer

      Farhat Nasim22 April 2019 9:30 AM IST
      New Delhi: Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (USFDA) has approved...
      Merck Foundation defines interventions to break infertility stigma at IFFS World Congress

      Merck Foundation defines interventions to break infertility stigma at IFFS World Congress

      Farhat Nasim21 April 2019 9:30 AM IST
      Minister of Health, Republic of The Gambia said together with Merck Foundation, we want to remove the stigma associated with it by creating a cultural...
      AMO Pharma launches clinician-completed rating scale for congenital myotonic dystrophy type 1

      AMO Pharma launches clinician-completed rating scale for congenital myotonic dystrophy type 1

      Farhat Nasim21 April 2019 9:15 AM IST
      LONDON: AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company focusing on rare, childhood-onset neurogenetic disorders with...
      Lower dose of Pfizer, Eli Lilly blockbuster painkiller tanezumab misses target in late stage study

      Lower dose of Pfizer, Eli Lilly blockbuster painkiller tanezumab misses target in late stage study

      Farhat Nasim20 April 2019 10:00 AM IST
      The drug, tanezumab, belongs to a new category of pain medications that target nerve growth factor, a protein involved in the growth of nerve cells,...
      Xyphos Biosciences ACCEL technology platform gets US patent

      Xyphos Biosciences' ACCEL technology platform gets US patent

      Farhat Nasim20 April 2019 9:15 AM IST
      California: Xyphos Biosciences Inc. recently announced the issuance of U.S. Patent No. 10,259,858, entitled “Insertable Variable Fragments of...
      Aurobindo Pharma recalls 88600 vials of Lidocaine injections from US

      Aurobindo Pharma recalls 88600 vials of Lidocaine injections from US

      Farhat Nasim19 April 2019 10:00 AM IST
      Lidocaine HCl injection is a medication used for local or regional anaesthesia to perform certain surgeries and procedures.New Delhi: Aurobindo Pharma...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok